Belgium· BE-AMP-SAM267513-00
Telzir 50 mg/ml
A fosamprenavir product containing fosamprenavir calcium, registered in Belgium by ViiV Healthcare. The same ATC class is registered in 8 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Fosamprenavir is registered in 8 of 19 countries.
Countries holding a registration under ATC J05AE07 (fosamprenavir), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Fosamprenavir · ATC J05AE07
8 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Franceprice
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fosamprenavir costs, country by country.
Normalised to the WHO defined daily dose (1.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Fosamprenavir · price per daily dose (1.4 g)
USD · FX 28 Sept 2026
- FR France$13.86
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Fosamprenavir Calcium
- Manufacturer
- ViiV Healthcare
- Country
- Belgium (BE)
- ATC code
- J05AE07
- ATC class
- Fosamprenavir
- Defined daily dose
- 1.4 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb2133353
- be_apb0779330
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
336 interactions on record for fosamprenavir.
Graded by severity as the source publishes them — 116 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fosamprenavir · interactions on record
336 records
- 116 severe
- 186 moderate
- 7 minor
- 25 info
Most severe, free to view
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- LoperamideA07DA03severe
- BudesonideA07EA06severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fosamprenavir in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainTELZIR 50 MG/ML SUSPENSION ORALViiv Healthcare B.V.
- FinlandTelzirViiV Healthcare BV
- FranceTELZIR 50 mg/ml, suspension buvableVIIV HEALTHCARE UK (ROYAUME-UNI)
- PolandTelzirViiV Healthcare BV
- United StatesFosamprenavir CalciumSun Pharmaceutical Industries, Inc.
- United KingdomTelzir 50mg/ml oral suspensionViiV Healthcare UK Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0af2a1e3-8fc2-492e-b355-5e56d4da0032 GET /v1/drugs/0af2a1e3-8fc2-492e-b355-5e56d4da0032?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oral suspension",
"source": "afmps",
"status": "REVOKED",
"name_en": "Telzir 50 mg/ml",
"name_fr": "Telzir 50 mg/ml",
"name_nl": "Telzir 50 mg/ml",
"amp_code": "SAM267513-00",
"strengths": [
"50.0000",
"50.0000"
],
"pack_count": 1,
"substances": [
"Fosamprenavir Calcium",
"Fosamprenavir"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Fosamprenavir",
"authorisation_numbers": [
"EU/1/04/282/002"
]
}See everything about fosamprenavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.